Glucosamine and osteoarthritis: Time to quit?

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 3, 2011, Pages 233-234

  Muniyappa, Ranganath ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; GLUCOSAMINE; GLUCOSE; HEXOSAMINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE; DRUG BLOOD LEVEL; DRUG EFFICACY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; GLUCOSAMINE; GLUCOSE; GLYCOSAMINOGLYCANS; HUMANS; INSULIN RESISTANCE; OSTEOARTHRITIS;

EID: 79952160646     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1179     Document Type: Article

References (6)

1. Reginster JY, Bruyere O, Neuprez A. Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 2007; 46: 731-735.
2. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58: 26-35.
3. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cart 18: 476-499.
4. Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 2006; 290: E1-E8.
5. Silbert JE. Dietary glucosamine under question. Glycobiology 2009; 19: 564-567.
6. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341: c4675.